Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

August 1, 2028

Study Completion Date

August 1, 2028

Conditions
HIV Infections
Interventions
BEHAVIORAL

ACCESS Intervention

Participants will receive the ACCESS intervention with funding, consisting of up to 16 hours of practice facilitation per month in person and/or virtually. Practice facilitation is training and support on implementation of routine HIV/HCV screening.

BEHAVIORAL

Control Group

Participants will receive a link to the CDC compendium of evidence-based interventions for HIV prevention.

Trial Locations (1)

33136

RECRUITING

University of Miami, Miami

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Miami

OTHER

NCT06730555 - Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID) | Biotech Hunter | Biotech Hunter